Exicure

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exicure and other ETFs, options, and stocks.

About XCUR

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN.

CEO

Matthias G. Schroff

CEOMatthias G. Schroff

Employees

Employees47

Headquarters

Chicago, Illinois

HeadquartersChicago, Illinois

Founded

2011

Founded2011

Employees

Employees47

XCUR Key Statistics

Market cap

7.84M

Market cap7.84M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

84.52K

Average volume84.52K

High today

$1.67

High today$1.67

Low today

$1.47

Low today$1.47

Open price

$1.47

Open price$1.47

Volume

24.89K

Volume24.89K

52 Week high

$39.00

52 Week high$39.00

52 Week low

$1.36

52 Week low$1.36

XCUR Earnings

-$8.10

-$5.40

-$2.70

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 14, After Hours

ActualExpected Nov 14, After Hours

Exicure

Why Robinhood?

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. Show more

XCUR Key Statistics

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN.